Sandoz
Top Ten most popular articles on Pharmafile.com this week!
April 26, 2019Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Aduro Biotech, Cancer, GSK, ICR, J&J, JJ, Novartis, Sandoz, pharma
The Institute for Cancer Research (ICR) called for new measures to increase the speed with which patients in the UK …
Senior GSK exec Richard Saynor revealed as new Sandoz CEO
April 25, 2019Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Novartis, Sandoz, appointment, pharma
Novartis has seen a major leadership change within its business, as the company announced that senior GlaxoSmithKline exec Richard Saynor …
Top Ten most popular articles on Pharmafile.com this week!
March 22, 2019Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AstraZeneca, Biogen, Eisai, FDA, Merck, NICE, Pfizer, Roche, Sandoz
This week was a bad week for clinical trials. While the FDA put Roche and AbbVie’s multiple myeloma trial on …
Top Ten most popular articles on Pharmafile.com this week!
March 15, 2019Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Acadia Pharmaceuticals, FDA, Sandoz, brexit, genomics, pharma, pharmacovigilance, top 10
The US Department of Justice has launched an investigation into the sales and marketing practices of San Diego firm Acadia …
Sandoz CEO Richard Francis to step down
March 14, 2019Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing CEO, Novartis, Sandoz, appointment, pharma
Richard Francis is set to step down his role as Chief Executive of Novartis’ generics arm Sandoz after five years’ …
Indivior launches authorised generic version of opioid addiction treatment Suboxone as rival generic drugmakers enter market
February 21, 2019Sales and Marketing Alvogen, Dr Reddy's, Novartis, Sandoz, indivior
Indivior has announced the launch of an authorised generic version of Suboxone Film (buprenorphine/naloxone) a combination medicine used to treat …
Novartis inks deal with Canadian cannabis firm Tilray
December 18, 2018Research and Development Marijuana, Novartis, Sandoz, Tilray, cannabis
Shares in Canadian cannabis company Tilray jumped by more than 11% today after the British Columbia-based firm announced its entry …
NHS to save £300 million by switching to Humira biosimilars
November 27, 2018Manufacturing and Production, Sales and Marketing AbbVie, Humira, Mylan, NHS, Sandoz, adalimumab, biosimilars, pharrma
NHS England has announced that the health service is set to save £300 million by switching to biosimilar versions of …
Novartis denies potential split with Sandoz
November 15, 2018Business Services, Manufacturing and Production Business, M&A, MA, Novartis, Sandoz, acquisition, mergers
Swiss newspaper Tages-Anzeiger has reported that Novartis is preparing for a split with long-term partner Sandoz. The two companies merged …
Novartis sells key Sandoz US portfolios to Aurobindo for $1bn
September 6, 2018Sales and Marketing Aurobindo, Novartis, Sandoz, pharma
Novartis has revealed it is to sell the dermatology and generic US oral solids portfolios of its generics arm Sandoz …
EU Commission grants market authorisation for Sandoz’ Humira biosimilar
July 30, 2018Sales and Marketing FDA, Sandoz, approval, biosimilar, european commision
The European Commission has granted marketing authorisation to Sandoz’ biosimilar Hyrimoz for use in all indications, including rheumatoid arthritis, plaque …
Head of Sandoz UK becomes BGMA chair
May 31, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Sandoz, appointment, bgma, pharma
Tim de Gavre has been announced as the new chair for the British Generic Manufacturers Association (BGMA), a position he …
Novartis’ Sandoz scores EU approval for Remicade biosimilar
May 24, 2018Sales and Marketing EU, Europe, Novartis, Remicade, Sandoz, Zessly, pharma
The European Commission has given its approval to Sandoz, Novartis’ generics and biosimilars unit, for its biosimilar version of Janssen’s …
Top Ten most popular articles on Pharmafile.com this week
May 4, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing BMS, EMA, Kymriah, Novartis, Porton Biopharma, Regeneron, Roche, Sandoz, Sanofi, Shire, Takeda, biosimilars, dementia
It’s Friday again and it’s been a week busy with companies’ financials. One company’s in particular were of note due …
Sandoz US woes continue with biosimilar rejection
May 3, 2018Sales and Marketing Novartis, Sandoz, biosimilars, biotech, drugs, pharma, pharmaceutical
In Novartis’ recently released Q1 results, which largely beat analysts’ estimates, Sandoz was a black spot on its record – …
Latest content
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions
